Research programme: anticancer monoclonal antibodies and protein therapeutics - Fusion Antibodies

Drug Profile

Research programme: anticancer monoclonal antibodies and protein therapeutics - Fusion Antibodies

Alternative Names: Fsn 0306; Fsn 0503; Fsn 0503h; Fsn 1006; Fsn 1103; Fsn 1107

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Fusion Antibodies
  • Class Monoclonal antibodies; Recombinant proteins
  • Mechanism of Action Angiogenesis inhibitors; Cathepsin S inhibitors; Cysteine endopeptidase inhibitors; Heparin binding EGF like growth factor inhibitors; MDK protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Cancer; Solid tumours
  • Discontinued Multiple myeloma

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Ireland (Parenteral)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Solid-tumours in Ireland (Parenteral)
  • 02 Aug 2013 Fsn 1006 is available for licensing as of 09 Nov 2012. http://fusionantibodies.com/
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top